financetom
Business
financetom
/
Business
/
US FDA approves Amneal's migraine treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Amneal's migraine treatment
May 26, 2025 8:31 AM

May 15 (Reuters) - Amneal Pharmaceuticals ( AMRX ) said

on Thursday the U.S. Food and Drug Administration has approved

its self-administered migraine drug.

(Reporting by Mariam Sunny in Bengaluru; Editing by Devika

Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved